Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | PDIK1L | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | SCAI | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | PHF21B | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | ZNF837 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | SF3A2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | TMPO | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | MCM2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | ELL2 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
mRNA | DDX25 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |